EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Evaluating Serum Adiponectin Levels with Respect to the Results of Oral Glucose Tolerance Test in Dysglycemic Pregnant Females

Ali H. Shaalan, Mudhafar S. Khazaal

Academic International Journal of Medical Sciences · 2024

DOI: 10.59675/m123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic International Journal of Medical Sciences, 2024. Verfasst von Ali H. Shaalan und 1 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hormone adiponectin has antidiabetic and anti-inflammatory effects. Gestational diabetes is hyperglycemia that develops in middle of pregnancy. The oral glucose tolerance test is used to screen for gestational diabetes. As a measure for insulin resistance, the (QUICKI-index), utilizes fasting insulin and fasting glucose levels to evaluate the sensitivity to insulin. Pregnancy is a state of insulin resistance and the role played by the adiponectin in the progression from euglycemia into prediabetes is a matter of conflict. Aim: to evaluate adiponectin levels in pregnancy and to find out if it can be used as a marker for developing GDM. Subjects and methods: a cross-sectional study involved 40 pregnants of 18–40 years of age at their second trimester and having BMI of 25-30 Kg/m2. After performing the OGTT, pregnants were divided into: Impaired glucose tolerance (IGTT) group: 23 pregnant with a mean age of 25.9 ± 6.1 years. B. Gestational diabetes (GDM) group: 13 pregnant with an age of 29.5 ± 3.9 years. The following parameters were measured: FBG, 2-hour RBG, fasting insulin, serum adiponectin, QUICKI-index. Results: There was no significant statistical difference with respect to; age (p= .855), BMI (p= .071), and gestational age (p= .239). Serum adiponectin was significantly lower in the GDM group (p= .028). The FBG was significantly higher in the GDM group, (p

Zitieren

APA

Shaalan, A. H., & Khazaal, M. S. (2024). Evaluating Serum Adiponectin Levels with Respect to the Results of Oral Glucose Tolerance Test in Dysglycemic Pregnant Females. Academic International Journal of Medical Sciences. https://doi.org/10.59675/m123

Vancouver

Shaalan AH, Khazaal MS. Evaluating Serum Adiponectin Levels with Respect to the Results of Oral Glucose Tolerance Test in Dysglycemic Pregnant Females. Academic International Journal of Medical Sciences. 2024. doi:10.59675/m123

BibTeX
@article{Shaalan2024,
  author = {Shaalan, Ali H. and Khazaal, Mudhafar S.},
  title = {Evaluating Serum Adiponectin Levels with Respect to the Results of Oral Glucose Tolerance Test in Dysglycemic Pregnant Females},
  journal = {Academic International Journal of Medical Sciences},
  year = {2024},
  doi = {10.59675/m123}
}
Kostenlos starten →